Understanding HIV Risk for People Who Inject Drugs During and After the Pandemic
Risk Factors for AIDS among persons who inject drugs: HIV transmission during and after the pandemic
This project looks at how the recent pandemic might have changed HIV risks for people who inject drugs in New York City.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10863963 on NIH RePORTER |
What this research studies
The pandemic created conditions that could lead to new HIV outbreaks among people who inject drugs, similar to what happened before the pandemic. Things like economic hardship, disruptions in HIV prevention services, and the rise of new injectable drugs like fentanyl might increase risk. We want to understand how these changes, especially in New York City, affect HIV risk behaviors during and after the pandemic. This helps us learn how to better prevent HIV in the future.
Who could benefit from this research
Good fit: This work focuses on understanding risk factors among people who inject drugs in New York City, rather than direct patient participation in a clinical intervention.
Not a fit: Patients not in the specific population of people who inject drugs in New York City would not directly benefit from this particular research.
Why it matters
Potential benefit: If successful, this work could lead to better strategies for preventing HIV transmission among people who inject drugs, especially during public health crises.
How similar studies have performed: Past outbreaks of HIV among people who inject drugs have shown common features, suggesting that understanding these patterns can help prevent future transmissions.
Where this research is happening
New York, United States
- New York University — New York, United States (Active)
Researchers
- Principal investigator: Mcknight, Courtney — New York University
- Study coordinator: Mcknight, Courtney
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.